A cost‐effectiveness analysis of hormone replacement therapy in the menopause∗

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Medical Journal of Australia

• Publication date

  1992-03-01

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.5694/j.1326-5377.1992.tb139784.xPMID 1588862
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Life Contingencies

  2014cited by this paper
• Costing acute myocardial infarction in New South Wales, Australia, based on incidence rather than prevalence methods.

  2010cited by this paper
• Epidemiology of cancer in South Australia. Incidence, mortality and survival 1977 to 1989

  1991cited by this paper
• Consensus development conference: prophylaxis and treatment of osteoporosis.

  1991cited by this paper
• The risk of breast cancer after estrogen and estrogen-progestin replacement.

  1989cited by this paper
• Oestrogen therapy after the menopause — boon or bane?

  1988cited by this paper
• Postmenopausal oestrogen treatment and stroke: a prospective study.

  1988cited by this paper
• Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study.

  1987cited by this paper
• Methods for the economic evaluation of health care programmes

  1987cited by this paper
• Consensus development conference: prophylaxis and treatment of osteoporosis.

  1987cited by this paper
• Challenges for Cost-effectiveness Research

  1986cited by this paper
• [Clinical decision analysis].

  1986cited by this paper
• Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in postmenopausal osteoporosis.

  1985cited by this paper
• The determination of the incidence of acute myocardial infarction from hospital morbidity records.

  1984cited by this paper
• Low-risk lipoprotein pattern in post-menopausal women on sequential oestrogen/progestogen treatment.

  1984cited by this paper
• Prognosis after myocardial infarction: results of 15 year follow up.

  1984cited by this paper
• The Minimum Effective Dose of Estrogen for Prevention of Postmenopausal Bone Loss

  1984cited by this paper
• Epidemiology of fractures of the distal forearm in Oslo, Norway.

  1983cited by this paper
• Combination Estrogen and Progestogen Replacement Therapy Does Not Adversely Affect Coagulation

  1983cited by this paper
• Hip fractures in the county of Funen, Denmark. Implications of demographic aging and changes in incidence rates.

  1983cited by this paper
• Cost-effectiveness of hormone replacement therapy in the menopause.

  1983cited by this paper
• Blood pressure and hemodynamics in postmenopausal women during estradiol-17 beta substitution.

  1983cited by this paper
• A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making.

  1982cited by this paper
• Blood pressure changes: oestrogens in climacteric women.

  1981cited by this paper
• Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.

  1981cited by this paper
• Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium.

  1981cited by this paper
• Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen.

  1980cited by this paper
• Predominance of early endometrial cancers after long-term estrogen use.

  1980cited by this paper
• Endometrial disease after treatment with oestrogens and progestogens in the climacteric.

  1980cited by this paper
• Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems.

  1979cited by this paper
• Mortality after hip fractures.

  1979cited by this paper
• Effects of long-term estrogen replacement therapy. I. Metabolic effects.

  1979cited by this paper
• A PROSPECTIVE, CONTROLLED TRIAL OF SIX FORMS OF HORMONE REPLACEMENT THERAPY GIVEN TO POSTMENOPAUSAL WOMEN

  1979cited by this paper
• BONE RESPONSE TO TERMINATION OF OESTROGEN TREATMENT

  1978cited by this paper
• Survival and ambulation following hip fracture.

  1978cited by this paper
• Foundations of cost-effectiveness analysis for health and medical practices.

  1977cited by this paper

• Risk of unplanned caesarean birth in Vietnamese-born women in Victoria, Australia: A cross-sectional study.

  2018cites this paper
• Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations

  2017cites this paper
• Multiple Comparison of Age Groups in Bone Mineral Density under Heteroscedasticity

  2015cites this paper
• A systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fractures

  2013cites this paper
• Economic Evaluation of Norethisterone Acetate/Ethinylestradiol (FemHRT®) for Women with Menopausal Symptoms

  2012cites this paper
• Assessing Generalisability in Model-Based Economic Evaluation Studies

  2012cites this paper
• Hip Fracture Prevention

  2012cites this paper
• Principles of health economics and application to rheumatic disorders

  2011cites this paper
• Use of Evidence in Decision Models

  2010cites this paper
• Cost-effectiveness analysis of hormone replacement therapy and lifestyle intervention for hip fracture.

  2010cites this paper
• Citología endometrial en pacientes posmenopáusicas con terapia hormonal

  2008cites this paper
• Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal women.

  2007cites this paper
• Postmenopausal hormone therapy increases use of health services: experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757].

  2006cites this paper
• PROFICIENCY CONTINUING EDUCATION : PHARMACY PRACTICE IN THE LONG-TERM CARE ENVIRONMENT LEARNING

  2005cites this paper
• Economic evaluations of interventions for the prevention and treatment of osteoporosis: a structured review of the literature

  2005cites this paper
• Costs and consequences of hip fracture occurrence in old age: An economic perspective

  2005cites this paper
• Assessment of the risk of osteoporosis at the menopause: Therapeutic consequences

  2005cites this paper
• Direct clinical and welfare costs of osteoporotic fractures in elderly men and women

  2005cites this paper
• Prevention of osteoporosis: Cost-effectiveness of different pharmaceutical treatments

  2005cites this paper
• Alendronate and hormone replacement therapy in the prevention of osteoporotic fracture: a pharmacoeconomic analysis employing a net-benefit regression method of cost-effectiveness

  2004cites this paper
• Generalisability in economic evaluation studies in healthcare: a review and case studies.

  2004cites this paper
• Reassessment of the cost-effectiveness of hormone replacement therapy in Sweden: Results based on the Women's Health Initiative randomized controlled trial

  2004cites this paper
• Fracturas en mujeres postmenopáusicas en el IMSS: frecuencia y costos de su atención hospitalaria

  2003cites this paper
• Do HEDIS measures reflect cost-effective practices?

  2002cites this paper
• Converting international cost effectiveness data to UK prices

  2002cites this paper
• [Pharmaco-economic evaluation of drug therapy osteoporosis. A literature review].

  2002cites this paper
• Models for Assessing the Cost-Effectiveness of the Treatment and Prevention of Osteoporosis

  2002cites this paper
• Economics notes: Converting international cost effectiveness data to UK prices.

  2002cites this paper
• Treatment of established osteoporosis: a systematic review and cost-utility analysis.

  2002cites this paper
• Scottish Intercollegiate Guidelines Network Prevention and Management of Hip Fracture in Older People

  2002cites this paper
• Una experiencia de capacitación sobre climaterio y menopausia entre médicos del IMSS

  2002cites this paper
• Direct Medical Costs Attributable to Osteoporotic Fractures

  2002cites this paper
• Equity and the economic evaluation of healthcare.

  2001cites this paper
• Hip fracture prevention: cost-effective strategies.

  2001cites this paper
• Pharmacoeconomics of Cardiovascular Medicine

  2001cites this paper
• The Economic Cost of Hip Fractures Among Elderly Women: A One-Year, Prospective, Observational Cohort Study with Matched-Pair Analysis

  2001cites this paper
• Economic Evaluation of Three Preventive Drug Therapies for Osteoporotic Fractures among Women at Different Risk levels

  2001cites this paper
• Issues in the Economic Evaluation of Treatments for Menopausal Symptoms

  2001cites this paper
• Has the Impact of Hormone Replacement Therapy on Health-Related Quality of Life Been Undervalued?

  2000cites this paper
• Cost-utility analyses of clinical preventive services1

  2000cites this paper
• Preference-based measures in economic evaluation in health care.

  2000cites this paper
• Economic Impact of Tibolone Compared with Continuous-Combined Hormone Replacement Therapy

  2000cites this paper
• A concise review of the cost-effectiveness of coronary heart disease prevention.

  2000cites this paper
• CHAPTER 46 – Decision Analysis Applied to Postmenopausal Hormone Replacement Therapy

  2000cites this paper
• The economics and management of cardiovascular disease in postmenopausal women

  2000cites this paper
• Cost‐effectiveness research in osteoporosis

  2000cites this paper
• A CONCISE REVIEW OF THE CORONARY HEART DISEASE PREVENTION COST-EFFECTIVENESS OF

  2000cites this paper
• Cost-utility analyses of clinical preventive services: published ratios, 1976-1997.

  2000cites this paper
• Models of intervention in menopause: proposal of a holistic or integral model.

  1999cites this paper
• A critical structured review of economic evaluations of interventions for the prevention and treatment of osteoporosis

  1999influential citation
• Effect and Offset of Effect of Treatments for Hip Fracture on Health Outcomes

  1999cites this paper
• Livial: an economic appraisal.

  1999cites this paper
• A review of economic evaluation in osteoporosis.

  1999cites this paper
• Self-assessment of somatic and psychic symptoms during a two months period of hormone replacement therapy in perimenopausal women

  1999cites this paper
• Willingness to pay for hormone replacement therapy.

  1998cites this paper
• Methods of assessing the impact of climacteric complaints on quality of life.

  1998cites this paper
• Cost Effectiveness of Coronary Heart Disease Prevention Strategies in Adults

  1998influential citation
• Relationship of compliance with hormone replacement therapy to short-term healthcare utilization in a managed care population.

  1998cites this paper
• Lebensqualität bei Schlafstörungen im Rahmen eines postmenopausalen Syndroms

  1998cites this paper
• A summary of economic evaluations published in the field of rheumatology and related disciplines.

  1997cites this paper
• Economic evaluation of interventions in endocrinology.

  1997cites this paper
• Estimating the cost per avoided hip fracture by osteoporosis treatment in Italy.

  1997cites this paper
• The socioeconomic burden of fractures: today and in the 21st century.

  1997cites this paper
• The Economics of Osteoporosis and Its Prevention

  1997cites this paper
• Progestogen intolerance and compliance with hormone replacement therapy in menopausal women.

  1997cites this paper
• The economics of osteoporosis prevention.

  1997cites this paper
• Decision analysis in endocrinology and metabolism.

  1997cites this paper
• Attitudes and Beliefs of Family Physicians and Gynecologists in Relation to the Prevention and Treatment of Osteoporosis

  1997cites this paper
• The economics of osteoporosis and its prevention. A review.

  1997cites this paper
• The impact of hormone replacement therapy on quality of life and willingness to pay

  1997cites this paper
• Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis.

  1996cites this paper
• Ostéoporose : Stratégies de prévention et de traitement

  1996cites this paper
• Effect of physician gender on the prescription of estrogen replacement therapy

  1996cites this paper
• Menopause and osteoporosis: the role of HRT.

  1996cites this paper
• Hormone replacement therapy in a risk-benefit perspective.

  1996cites this paper
• Clinical outcomes and mortality after hip fracture: a 2-year follow-up study.

  1996cites this paper
• Hormone replacement therapy: compliance and cost after screening for osteoporosis.

  1995cites this paper
• Sensitivity analysis in economic evaluation: a review of published studies.

  1995cites this paper
• Effectiveness and Costs of Osteoporosis Screening and Hormone Replacement Therapy

  1995cites this paper
• A critical review of health-related economic evaluations in Australia: implications for health policy.

  1995cites this paper
• Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency.

  1994cites this paper
• Hormone Replacement Therapy

  1994cites this paper
• Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.

  1994cites this paper
• Symptomatic fracture incidence in elderly men and women: The Dubbo osteoporosis epidemiology study (DOES)

  1994cites this paper
• The prevention of cardiovascular disease. Emphasis on secondary prevention.

  1994cites this paper
• 5 Oestrogens and atherosclerotic vascular disease—lipid factors

  1993cites this paper
• Epidemiological overview of oestrogen replacement and cardiovascular disease.

  1993cites this paper
• 6 Epidemiological overview of oestrogen replacement and cardiovascular disease

  1993cites this paper
• The prevalence of oestrogen replacement therapy in South Australia.

  1993cites this paper
• Intraoperative use of thrombolytic agents. Procedure requires appropriate imaging.

  1993cites this paper
• Oestrogens and atherosclerotic vascular disease--lipid factors.

  1993cites this paper
• Hormone replacement therapy. Risks, benefits, and costs.

  1993cites this paper
• The prevalence of hysterectomy in South Australia

  1993cites this paper
• Hormone replacement therapy and cancer.

  1993cites this paper
• Impact of menopausal symptoms: Authors' reply

  1993cites this paper
• 7 Hormone replacement therapy and cancer

  1993cites this paper
• Impact of menopausal symptoms. Study perpetuates false impression.

  1993cites this paper
• Osteoporosis prevention through screening: will it be cost effective?

  1993cites this paper